RESEARCH
Keio University WPI-Bio2Q Publication
August 17, 2023
Transcription of MERVL retrotransposons is required for preimplantation embryo development
Nature Genetics. 2023; 55: 484–495
DOI: 10.1038/s41588-023-01324-y
Akihiko Sakashita1,3, Tomohiro Kitano 1,3, Hirotsugu Ishizu1, Youjia Guo 1,
Harumi Masuda1, Masaru Ariura1, Kensaku Murano 1 & Haruhiko Siomi 1,2
1Department of Molecular Biology, Keio University School of Medicine, Tokyo, Japan.
2Human Biology Microbiome Quantum Research Center (WPI-Bio2Q), Keio University, Tokyo, Japan.
3These authors contributed equally: Akihiko Sakashita, Tomohiro Kitano.
SHARE
More Bio2Q News
WPI-Bio2Q Events with Shingo Kajimura, Ph.D
WPI-Bio2Q welcomed Dr. Shingo Kajimura, its International Collaborator and Professor of Medicine, Harvard Medical School to Japan from July ...
WPI-Bio2Q now recruiting administrative staff 事務スタッフ募集中(8/18...
WPI-Bio2Q Administrative Office is currently hiring administrative staff for FY2024. We look forward to receiving applications from cand...
WPI-Bio2Q Open Seminar by Robert R Jenq, M.D. on July 26
On Friday, July 26, the Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold an open seminar at Shinanomac...
WPI-Bio2Q Open Seminar by Sungwhan Oh, Ph.D. on July 19 (for...
July 19, 2024 - WPI-Bio2Q Open Seminar by Sungwhan Oh, Ph.D. will be held at Shiba-Kyoritsu Campus. Title: "Mining Bioactive Metabo...
WPI-Bio2Q Open Seminars by Shingo Kajimura, Ph.D. on July 12...
Dr. Shingo Kajimura, International Collaborator of WPI-Bio2Q and Investigator, Howard Hughes Medical Institute and Beth Israel Deaconess Med...